Gamma Investing LLC Roivant Sciences Ltd. Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gamma Investing LLC holds 2,093 shares of ROIV stock, worth $25,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,093
Previous 1,257
66.51%
Holding current value
$25,220
Previous $13.2 Million
66.98%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$860 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$833 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$804 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$426 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$353 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.49B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...